Verified peer comparison
Seres Therapeutics vs ABVC BioPharma Financial Comparison
Direct answer
Seres Therapeutics and ABVC BioPharma are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Seres Therapeutics Revenue
- 789,000 USD
- ABVC BioPharma Revenue
- 795,950 USD
- Seres Therapeutics Operating income
- -93,971,000 USD
- ABVC BioPharma Operating income
- -7,151,259 USD